We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Preservative Stabilizes Residual White Cells in Leuko-Reduced Samples

By LabMedica International staff writers
Posted on 20 May 2009
A preservative specifically stabilizes residual white blood cells (rWBCs) in leuko-reduced red blood cell samples.

Compatible with commercially available kits, Leuko Preserve is intended for detection and enumeration of rWBCs by flow cytometric analysis. More...
Flow cytometric enumeration of rWBCs in leuko-reduced blood components must be implemented within 48 hours. Occasionally, problems occur making this difficult.

Streck's (Omaha, NE, USA) Leuko Preserve stabilizes rWBCs for up to seven days following leuko-reduction, extending the timeframe for enumeration. This reduces concerns of sample backlogs, instrument problems, and shipping delays.

Additional Streck cell stabilization products include Streck Cell Preservative for the preservation of bone marrow and tissue samples; Cyto-Chex BCT (Blood Collection Tube) for the preservation of whole blood samples for immunophenotyping by flow cytometry; and Cell-Free DNA BCT, a new blood collection tube for the preservation of cell-free plasma DNA. Cell-Free DNA BCT is for research use only.

Streck has also increased the stability of its three-part Para Check whole blood hematology control. Manufactured specifically for the Sysmex KX-21, pocH-100i, and the SweLab AC920EO, the three-part control now offers closed-vial stability of 132 days. The extended closed-vial stability will allow customers to maintain a quarterly ordering schedule, decreasing shipping costs and increasing the ILQC (interlaboratory quality control) peer groups for each instrument on the assay. Para Check is available in a 2.5-ml or 3.5-ml vial with a pierceable cap to accommodate both open- and closed-mode systems.

STATS, a free interlaboratory quality control program, is offered to all Para Check customers. STATS produces relevant peer group comparison reports and graphs with a quick turnaround time. Data can be submitted by mail, fax or e-mail. The reports include customer data, peer group averages, and computer-generated Levey-Jennings graphs.

Streck is an independent developer and manufacturer of controls for the clinical laboratory.

Related Links:

Streck



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.